Leveraging genomic biobanks to enhance genetic testing outcomes for kidney disease
Gretchen M. Urban, Kulsoom Mohammad, Lakshna Sankar, Meei‐Hua Lin, Bryn S. Moore, Mohammad Alkhateeb, Badar Shah, Judith Savige, Peter C. Harris, Marc S. Williams, Tomohiko Yamamura, Tomoko Horinouchi, Kandai Nozu, Jeffrey H. Miner, Ana Morales, Alex R. Chang
This study evaluates genetic testing outcomes for kidney disease, finding 34% of patients had pathogenic variants, 52% had variants of uncertain significance (VUS), and multidisciplinary review with biobank data helped reclassify some VUS.
medRxiv · Nov 7, 2025 · PreprintGenetic & Genomic Medicine